<DOC>
	<DOC>NCT00516737</DOC>
	<brief_summary>The purpose of this study is to test the effectiveness of rizatriptan benzoate in the early treatment of an acute migraine attack.</brief_summary>
	<brief_title>Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>Greater than one year history of migraine Attacks typically mild when they begin and progress to moderate or severe Experience 14 migraine attacks per month More than 15 headache days per month Heart disease Uncontrolled high blood pressure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>